Articles with "erlotinib resistance" as a keyword



Photo from wikipedia

Rab25 promotes erlotinib resistance by activating the β1 integrin/AKT/β‐catenin pathway in NSCLC

Sign Up to like & get
recommendations!
Published in 2019 at "Cell Proliferation"

DOI: 10.1111/cpr.12592

Abstract: Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR‐TKI) has significant therapeutic efficacy in non‐small‐cell lung cancer (NSCLC) patients. However, acquired resistance is inevitable and limits the long‐term efficacy of EGFR‐TKI. Our study aimed to investigate… read more here.

Keywords: egfr tki; promotes erlotinib; erlotinib resistance; resistance ... See more keywords
Photo from wikipedia

Abstract 3142: Aberrantly expressed microRNAs drive the development of acquired Erlotinib resistance in non-small cell lung cancer

Sign Up to like & get
recommendations!
Published in 2017 at "Cancer Research"

DOI: 10.1158/1538-7445.am2017-3142

Abstract: Lung cancer is the leading cause of cancer-related deaths in the world. Non-small cell lung cancer (NSCLC) accounts for ~85% of the cases. NSCLC patients frequently harbor causal gene mutations. Epidermal Growth Factor Receptor (EGFR),… read more here.

Keywords: erlotinib resistance; resistance; cancer; cell ... See more keywords
Photo from wikipedia

NCAPG2 Maintains Cancer Stemness and Promotes Erlotinib Resistance in Lung Adenocarcinoma

Sign Up to like & get
recommendations!
Published in 2022 at "Cancers"

DOI: 10.3390/cancers14184395

Abstract: Simple Summary This study investigated the relationship between erlotinib resistance and stemness in lung adenocarcinoma. NCAPG2 was identified as an erlotinib resistance gene and maintained the stemness of lung adenocarcinoma. Abstract Erlotinib is a highly… read more here.

Keywords: lung adenocarcinoma; stemness; resistance; erlotinib resistance ... See more keywords

Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas: Erratum

Sign Up to like & get
recommendations!
Published in 2023 at "Theranostics"

DOI: 10.7150/thno.84874

Abstract: [This corrects the article DOI: 10.7150/thno.35729.]. read more here.

Keywords: resistance via; aldehyde dehydrogenase; erlotinib resistance; confers erlotinib ... See more keywords